| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.14 | 0.07 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.092 | 0.07 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.066 | 0.07 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.07 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.07 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.061 | 0.07 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.07 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.07 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.07 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.056 | 0.07 |